Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Retraction: Enhanced anti-tumor efficacy of hyaluronic acid modified nanocomposites combined with sonochemotherapy against subcutaneous and metastatic breast tumors

Pengying Wu a, Yue Sun b, Wei Dong a, Huige Zhou c, Shifang Guo a, Lei Zhang a, Xiaobing Wang *b, Mingxi Wan *a and Yujin Zong *a
aKey Laboratory of Biomedical Information Engineering of Ministry of Education, and Department of Biomedical Engineering, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, PR China. E-mail: yjzong@xjtu.edu.cn; mxwan@xjtu.edu.cn
bKey Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710119, PR China. E-mail: wangxiaobing@snnu.edu.cn
cCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanosciences, National Center for Nanoscience and Technology of China, No. 11 Beiyitiao, Zhongguancun, Beijing 100190, PR China

Received 7th November 2022 , Accepted 7th November 2022

First published on 15th November 2022


Abstract

Retraction of ‘Enhanced anti-tumor efficacy of hyaluronic acid modified nanocomposites combined with sonochemotherapy against subcutaneous and metastatic breast tumors’ by Pengying Wu et al., Nanoscale, 2019, 11, 11470–11483, https://doi.org/10.1039/C9NR01691K.


We, the named authors, hereby wholly retract this Nanoscale article.

At the request of Mingxi Wan and Yujin Zong, this Nanoscale article has been retracted due to the number of images with errors. The named authors hereby wholly retract this article.

In Fig. 6A there is overlap between the panels 0 h (f) and 0 h (h), and 24 h (a) and 24 h (b) and partial overlap between the panels 0 h (b) and 0 h (d), and 24 h (c) and 24 h (d).

In Fig. 6B there is partial overlap between the panels a, b, c and d, c and e, and f and g.

In Fig. 7 there is strong similarity between the free ICG panels 1 h, 3 h, 12 h and 24 h.

In Fig. 9 there is partial overlap between the panels (−) US HPCD, CD31 and (+) US HPCD, CD31.

In Fig. 10F there is partial overlap between the panels 3# and 4#.

In Fig. S7 there is partial overlap between the Heart panels 1# and 8#, and the Spleen panels 4# and 5#. There is overlap between the Liver panels 2# and 3#.

If interested readers need the corrected images, they can be provided by the first author Pengying Wu.

The named authors apologize to the readership for any inconvenience caused.

Signed: Pengying Wu, Yue Sun, Wei Dong, Huige Zhou, Shifang Guo, Lei Zhang, Xiaobing Wang, Mingxi Wan, Yujin Zong. 7th November 2022

Retraction endorsed by Heather Montgomery, Managing Editor, Nanoscale


This journal is © The Royal Society of Chemistry 2022
Click here to see how this site uses Cookies. View our privacy policy here.